Smith Julianne, Grizot Sylvestre, Arnould Sylvain, Duclert Aymeric, Epinat Jean-Charles, Chames Patrick, Prieto Jesús, Redondo Pilar, Blanco Francisco J, Bravo Jerónimo, Montoya Guillermo, Pâques Frédéric, Duchateau Philippe
CELLECTIS S.A., 102 route de Noisy, 93235 Romainville, France.
Nucleic Acids Res. 2006;34(22):e149. doi: 10.1093/nar/gkl720. Epub 2006 Nov 27.
Meganucleases, or homing endonucleases (HEs) are sequence-specific endonucleases with large (>14 bp) cleavage sites that can be used to induce efficient homologous gene targeting in cultured cells and plants. These findings have opened novel perspectives for genome engineering in a wide range of fields, including gene therapy. However, the number of identified HEs does not match the diversity of genomic sequences, and the probability of finding a homing site in a chosen gene is extremely low. Therefore, the design of artificial endonucleases with chosen specificities is under intense investigation. In this report, we describe the first artificial HEs whose specificity has been entirely redesigned to cleave a naturally occurring sequence. First, hundreds of novel endonucleases with locally altered substrate specificity were derived from I-CreI, a Chlamydomonas reinhardti protein belonging to the LAGLIDADG family of HEs. Second, distinct DNA-binding subdomains were identified within the protein. Third, we used these findings to assemble four sets of mutations into heterodimeric endonucleases cleaving a model target or a sequence from the human RAG1 gene. These results demonstrate that the plasticity of LAGLIDADG endonucleases allows extensive engineering, and provide a general method to create novel endonucleases with tailored specificities.
巨型核酸酶,即归巢内切酶(HEs),是具有大切割位点(>14 bp)的序列特异性内切酶,可用于在培养细胞和植物中诱导高效的同源基因靶向。这些发现为包括基因治疗在内的广泛领域的基因组工程开辟了新的前景。然而,已鉴定的HEs数量与基因组序列的多样性不匹配,在选定基因中找到归巢位点的概率极低。因此,具有选定特异性的人工内切酶的设计正在深入研究中。在本报告中,我们描述了第一种人工HEs,其特异性已被完全重新设计以切割天然存在的序列。首先,从I-CreI(一种属于HEs的LAGLIDADG家族的莱茵衣藻蛋白)衍生出数百种具有局部改变底物特异性的新型内切酶。其次,在该蛋白中鉴定出不同的DNA结合亚结构域。第三,我们利用这些发现将四组突变组装成切割模型靶点或人类RAG1基因序列的异二聚体内切酶。这些结果表明,LAGLIDADG内切酶的可塑性允许进行广泛的工程改造,并提供了一种创建具有定制特异性的新型内切酶的通用方法。